Goldman Sachs Initiates Coverage On National Healthcare with Buy Rating, Announces Price Target of $20
Benzinga Newsdesk 5 months ago
NewsPrice TargetInitiationAnalyst Ratings
Goldman Sachs analyst Julien Blouin initiates coverage on National Healthcare (NASDAQ:NHP) with a Buy rating and announces Price Target of $20.
Goldman Sachs analyst Julien Blouin initiates coverage on National Healthcare (NASDAQ:NHP) with a Buy rating and announces Price Target of $20.